Outlook Therapeutics, Inc. (OTLK)
Outlook Therapeutics, Inc. is a biopharmaceutical company in the advanced stages of clinical development, focused on inventing and bringing to market monoclonal antibody treatments for various eye conditions. Its flagship drug candidate, ONS-5010, is an ophthalmic formulation of bevacizumab currently undergoing crucial Phase III clinical trials. This investigational product is being evaluated for its potential to treat wet age-related macular degeneration and other serious retinal diseases. The company has forged strategic collaboration and licensing agreements with several partners, including IPCA Laboratories Limited, Laboratorios Liomont, S.A. de C.V., BioLexis Pte. Ltd., and Zhejiang Huahai Pharmaceutical Co., Ltd. Incorporated in 2010, the firm was formerly known as Oncobiologics, Inc., changing its name to Outlook Therapeutics, Inc. in November 2018. Its corporate base is located in Iselin, New Jersey.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Outlook Therapeutics, Inc.
NASDAQ:OTLKHealthcare · Biotechnology
-5.15%$0.4681
AH$0.4741+1.28%vs close
Mkt Cap$113.96M
Float204.15M
O/S243.45M
Vol
$ Vol
RVOL
Inst Own8.3%
SI16.0%
Earnings
Dilution
Financials Summary
Revenue$1.41M
Net Income-$62.42M
Total Assets$18.58M
Free Cash Flow-$51.83M
Debt & Equity
Total Debt$30.19M
Total Equity-$32.19M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
- 1:20Reverse splitMar 14, 202420 shares → 1
- 1:8Reverse splitMar 18, 20198 shares → 1
Balance Sheet Details
Assets$18.58M
Liabilities$50.77M
Accounts Receivable$1.49M
Accounts Payable$10.19M
Inventory$3.34M
PP&E (Net)$226K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 |
| Revenue | $1.41M | $0 | $0 | $0 | $0 | $0 | $8.15M | $3.09M | $3.81M | $2.98M | $5.22M | $9.05M |
| YoY Growth | - | - | - | - | - | - | 163.8% | -19.0% | 27.9% | -42.9% | -42.3% | - |
| Cost of Revenue | $756K | $0 | $0 | $205K | $0 | $554K | $23.8M | $18.5M | $23.81M | $0 | $0 | $0 |
| Gross Profit | $657K | $0 | $0 | -$205K | $0 | -$554K | -$15.66M | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | 46.5% | - | - | - | - | - | -192.2% | - | - | - | - | - |
| Research and Development | $27.78M | $41.76M | $26.45M | $42.33M | $38.96M | $26.34M | $23.8M | $18.5M | $23.81M | $32.76M | $38.88M | $14.13M |
| Selling, General, and Administrative | $39.94M | $29.94M | $26.67M | $20.74M | $12.77M | $8.08M | $9.37M | $14.23M | $15.88M | $21.56M | $12.91M | $7.32M |
| Other | $0 | $0 | $0 | -$205K | $0 | $1 | $11.27M | $0 | -$23.81M | $0 | $0 | $0 |
| Total Operating Expenses | $67.72M | $71.7M | $53.13M | $62.87M | $51.73M | $34.42M | $44.45M | $32.73M | $39.69M | $21.56M | $51.78M | $21.44M |
| Operating Income (EBIT) | -$67.06M | -$71.7M | -$53.13M | -$63.07M | -$51.73M | -$34.97M | -$36.3M | -$29.64M | -$35.88M | -$51.35M | -$46.56M | -$12.39M |
| Operating Margin | -4744.3% | - | - | - | - | - | -445.6% | -960.0% | -941.2% | -1723.1% | -892.2% | -136.9% |
| Interest Expense | $283K | $3.16M | $2.53M | $1.49M | $936K | $1.76M | $3.47M | $3.89M | $5.63M | $1.85M | $2.3M | $901K |
| Interest Income | $90K | $906K | $971K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $3.08M | -$3.66M | -$5.85M | -$2.98M | -$1.43M | -$3.54M | -$1.64M | -$4.1M | -$2.47M | -$1.85M | -$2.3M | -$901K |
| Income Before Tax (EBT) | -$63.98M | -$75.36M | -$58.98M | -$66.05M | -$53.16M | -$38.51M | -$37.94M | -$33.74M | -$38.35M | -$53.2M | -$48.86M | -$13.29M |
| Income Tax Expense | -$1.55M | $3K | $3K | $3K | $2K | -$3.27M | -$3.41M | -$3.65M | $502K | $103K | -$190K | $439K |
| Net Income | -$62.42M | -$75.37M | -$58.98M | -$66.05M | -$53.16M | -$35.24M | -$34.52M | -$30.09M | -$38.85M | -$53.3M | -$47.39M | -$13.73M |
| Net Income Margin | -4416.2% | - | - | - | - | - | -423.8% | -974.5% | -1019.1% | -1788.7% | -908.1% | -151.7% |
| Supplementary Data | ||||||||||||
| EPS | -1.79 | -4.06 | -4.80 | -6.23 | -7.00 | -13.47 | -39.60 | -194.80 | -267.20 | -587.20 | -564.14 | -1.05 |
| Diluted EPS | -1.79 | -4.06 | -4.80 | -6.23 | -7.00 | -13.47 | -39.60 | -85.00 | -288.00 | -587.20 | -564.14 | -1.05 |
| Weighted Average OS | 25.48M | 18.55M | 12.51M | 10.60M | 7.63M | 3.63M | 909,591 | 154,000 | 150,139 | 90,000 | 93,946 | 13.06M |
| EBITDA | -$63.58M | -$72.09M | -$56.4M | -$64.36M | -$51.96M | -$34.42M | -$31.11M | -$26.79M | -$30.03M | -$48.95M | -$44.74M | -$11.51M |
| EBITDA Margin | -4497.7% | - | - | - | - | - | -381.9% | -867.7% | -787.8% | -1642.7% | -857.2% | -127.2% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $8.08M | $14.93M | $23.39M | $17.4M | $14.48M | $12.54M | $8.02M | $1.72M | $3.19M | $2.35M | $2.35M | $9.07M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $8.08M | $14.93M | $23.39M | $17.4M | $14.48M | $12.54M | $8.02M | $1.72M | $3.19M | $2.35M | $2.35M | $9.07M |
| Accounts Receivable | $1.49M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4.3M | $4.3M |
| Inventory | $3.34M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $4.48M | $12.49M | $7.59M | $0 | $324 | $0 | $1.7M | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $17.39M | $27.42M | $30.98M | $27.52M | $21.51M | $17.94M | $13.5M | $3.3M | $3.9M | $5.68M | $3.15M | $15.16M |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $226K | $275K | $26K | $70K | $275K | $494K | $3.18M | $18.49M | $16.09M | $16.96M | $8.01M | $17.76M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $552K | $693K | $794K | $805K | $854K | $900K | $0 | $0 | $0 | $216K | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $418K | $439K | $501K | $132K | $175K | $394K | $457K | $491K | $740K | $853K | $448K | $2.08M |
| Total Long-Term Assets | $1.2M | $1.41M | $1.32M | $1.01M | $1.3M | $1.79M | $3.63M | $18.98M | $16.83M | $18.03M | $8.46M | $19.84M |
| Other Assets | $0 | $0 | $0 | $0 | -$451 | $449 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $18.58M | $28.82M | $32.3M | $28.53M | $22.81M | $19.73M | $17.13M | $22.28M | $20.73M | $23.71M | $11.6M | $35.01M |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $10.19M | $7.97M | $6.57M | $3.49M | $2.2M | $2.39M | $2.28M | $3.61M | $10.95M | $5.07M | $11.56M | $11.56M |
| Short-Term Debt | $29.95M | $29.44M | $35.55M | $10.92M | $904K | $3.66M | $11.34M | $17.86M | $4.67M | $5.2M | $14.96M | $14.96M |
| Current Income Tax Payable | $302B | $1.86M | $1.86M | $1.86M | $1.86M | $1.86M | $1.86M | $1.86M | $2.35M | $1.85M | $1.56M | $1.75M |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.74M | $3.09M | $1.21M | $1.5M | $1.98M |
| Other Current Liabilities | $3.03M | $1.01M | $1.83M | $1.98M | -$217 | $3.21M | $5.56M | $4.17M | $3.69M | $2.16M | -$12.44M | $2.98M |
| Total Current Liabilities | $45.81M | $42.55M | $46.73M | $19.73M | $6.75M | $15.89M | $20.29M | $32.04M | $28.74M | $20.44M | $20.21M | $37.04M |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $10.89M | $904K | $50K | $98K | $13.38M | $2.23M | $4.92M | $4.92M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.76M | $4.47M | $5.15M | $6.31M | $6.37M |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.45M | $2.27M | $0 | $4.66M | $14.43M |
| Other Long-Term Liabilities | $4.77M | $59.1M | $6K | $57K | $523K | $71K | $4.2M | $4.74M | $4.84M | $761K | $2.43M | $285K |
| Total Long-Term Liabilities | $4.96M | $59.35M | $6K | $61K | $11.45M | $1.02M | $7.61M | $11.05M | $22.72M | $8.47M | $14.94M | $27.22M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $50.77M | $101.9M | $46.74M | $19.79M | $18.2M | $16.91M | $27.9M | $43.09M | $51.46M | $28.91M | $35.15M | $64.26M |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $32.3T | $0 | $22.81T | $19.73T | $5.36M | $4.73M | $2.92M | $0 | $9.38M | $10.19M |
| Common Stock | $539K | $239K | $2.6M | $2.27M | $1.76M | $1.27M | $286K | $722K | $249K | $228K | $40K | $39.84M |
| Retained Earnings | -$605.71M | -$543.28M | -$467.92M | -$408.94M | -$342.88M | -$289.72M | -$254.48M | -$216.31M | -$186.22M | -$147.39M | -$45.15M | -$94.06M |
| Comprehensive Income & Other | $0 | $0 | -$32.3T | $0 | -$22.81T | -$19.73T | $0 | $190.76M | -$8.64M | -$5.96M | -$1.82M | -$3.64M |
| Other Stockholders' Equity | $572.98M | $469.97M | $450.88M | $415.4M | $345.73M | $291.27M | $243.42M | $194.77M | $155.24M | $141.97M | $21.56M | $25.62M |
| Total Equity | -$32.19M | -$73.08M | -$14.44M | $8.74M | $4.61M | $2.83M | -$10.77M | -$20.81M | -$30.73M | -$5.2M | -$23.55M | -$28.6M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1K | -$654K |
| Total Liabilities and Equity | $18.58M | $28.82M | $32.3M | $28.53M | $22.81M | $19.73M | $17.13M | $22.28M | $20.73M | $23.71M | $11.6M | $35.66M |
| Supplementary Data | ||||||||||||
| Total Debt | $30.19M | $29.74M | $35.56M | $10.96M | $11.9M | $8.8M | $14.95M | $21.93M | $18.42M | $8.73M | $15.17M | $21.96M |
| Net Debt | $22.11M | $14.81M | $12.16M | -$6.44M | -$2.57M | -$3.74M | $6.93M | $20.21M | $15.23M | $6.38M | $12.82M | $12.89M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 |
| Operating Activities | ||||||||||||
| Net Income | -$62.42M | -$75.37M | -$58.98M | -$66.05M | -$53.16M | -$35.24M | -$34.52M | -$46.11M | -$38.85M | -$53.33M | -$48.67M | -$13.73M |
| Depreciation & Amortization | $117K | $114K | $44K | $205K | $262K | $554K | $3.36M | $3.05M | $2.69M | $2.39M | $1.82M | $878K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $498K | $2.24M | $9.44M | $20.15M | -$3.1M | $14K | $0 | $0 |
| Stock-Based Compensation | $8.9M | $5.39M | $5.55M | $7.71M | $4.89M | $2.81M | $1.31M | $1.99M | $8.57M | $12.45M | $11.18M | $3.96M |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | -$1.49M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $20K | -$20K | $0 |
| Inventory | -$3.34M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$221K | $1.09M | $0 |
| Accounts Payable | $1.67M | $1.39M | $3.08M | $1.3M | -$198K | -$1.49M | -$1.33M | -$6.71M | $5.73M | -$5.33M | $6.58M | -$96K |
| Other Working Capital | $8.02M | -$4.41M | $1.67M | -$2.98M | -$6.88M | $220K | -$11.86M | -$6.97M | $5.44M | -$1.5M | $532K | $1.96M |
| Total Working Capital Change | $4.86M | -$3.02M | $4.75M | -$1.68M | -$7.08M | -$1.27M | -$13.19M | -$13.68M | $11.16M | -$7.02M | $8.18M | $1.86M |
| Other Non-Cash Items | -$3.28M | $4.09M | $5.66M | $3.15M | $342K | -$881K | $1.31M | $1.57M | $4.01M | $13K | $12K | $12K |
| Net Cash from Operating | -$51.83M | -$68.79M | -$42.97M | -$56.67M | -$54.25M | -$31.79M | -$32.29M | -$33.04M | -$15.51M | -$45.48M | -$27.48M | -$7.02M |
| Investing Activities | ||||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | -$437K | -$2.78M | -$292K | -$1.1M | -$8.8M | -$2.37M |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | -$900K | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | -$900K | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $900K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | -$900K | -$437K | -$2.78M | -$292K | -$1.1M | -$8.8M | -$2.37M |
| Financing Activities | ||||||||||||
| Debt Repaid | $3.04M | $4K | -$19.77M | $2.32M | -$6.31M | -$641K | $6.94M | $991K | -$11.33M | $13.34M | -$1.58M | -$4.39M |
| Common Stock Issuance | $48.03M | $60.33M | $30.02M | $62.31M | $46.3M | $35.43M | $45.96M | $14.7M | $1.61M | $53.21M | $41.25M | $11.04M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$226K | -$4.13M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$16.98B | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | -$824K | -$394K | $3.59M | $1.14M | $4K | -$1.09M | $16.99B | -$6K | $399K | $7.11M |
| Net Cash from Financing | $44.98M | $60.33M | $48.97M | $59.59M | $56.19M | $37.21M | $39.03M | $34.35M | $16.63M | $39.86M | $43M | $11.47M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$6.84M | -$8.46M | $6M | $2.92M | $1.94M | $4.52M | $6.3M | -$1.47M | $834K | -$6.72M | $6.72M | $2.09M |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | -$51.83M | -$68.79M | -$42.97M | -$56.67M | -$54.25M | -$31.79M | -$32.29M | -$33.04M | -$15.51M | -$45.48M | -$27.48M | -$7.02M |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | -$437K | -$2.78M | -$292K | -$1.1M | -$8.8M | -$2.37M |
| Free Cash Flow | -$51.83M | -$68.79M | -$42.97M | -$56.67M | -$54.25M | -$31.79M | -$32.73M | -$35.82M | -$15.8M | -$46.58M | -$36.28M | -$9.39M |
| Cash at Beginning | $14.93M | $23.39M | $17.4M | $14.48M | $12.54M | $8.02M | $1.72M | $3.19M | $2.35M | $9.07M | $2.35M | $262K |
| Cash at End | $8.08M | $14.93M | $23.39M | $17.4M | $14.48M | $12.54M | $8.02M | $1.72M | $3.19M | $2.35M | $9.07M | $2.35M |